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Differential Requirement for SLP-76 Domains
in T Cell Development and Function
(SLP-76) is an adaptor protein essential for thymocyte
development (Clements et al., 1998b; Pivniouk et al.,
1998), signaling through the mature TCR (Yablonski et
Peggy S. Myung,1,2 Geo S. Derimanov,2,3
Martha S. Jordan,2 Jennifer A. Punt,6 Qing-Hua Liu,4
Barbi A. Judd,7 Erin E. Meyers,2 Curt D. Sigmund,8
al., 1998), collagen-induced platelet activation (Clem-Bruce D. Freedman,4 and Gary A. Koretzky 2,5,9
ents et al., 1999), and FcR-dependent mast cell activa-1 Graduate Program in Immunology
tion (Pivniouk et al., 1999).University of Pennsylvania School of Medicine
SLP-76 consists of three protein interacting domains2 Signal Transduction Program
(Figure 1A). Its amino terminus carries tyrosine residues,Leonard and Madlyn Abramson
which become phosphorylated by syk-family protein ty-Family Cancer Research Institute
rosine kinases (PTKs) following TCR engagement (War-University of Pennsylvania School of Medicine
denburg et al., 1996). The central proline-rich region3 Department of Medicine
mediates an interaction with the SH3 domain of the Grb2Hospital of the University of Pennsylvania
homolog, Gads (also known as Grf40, GrpL, Mona, or4 Department of Pathobiology
GRID) (Asada et al., 1999; Bourette et al., 1998; Ellis etSchool of Veterinary Medicine
al., 2000; Law et al., 1999; Liu et al., 1999). The carboxy-University of Pennsylvania
terminal SH2 domain associates with another adaptor5 Department of Pathology and Laboratory Medicine
protein, ADAP (previously known as SLAP-130/Fyb),University of Pennsylvania School of Medicine
upon TCR-dependent ADAP phosphorylation (da SilvaPhiladelphia, Pennsylvania 19104
et al., 1997; Musci et al., 1997a). Additionally, an interac-6 Biology Department
tion between the SLP-76 SH2 domain and tyrosine-Haverford College
phosphorylated HPK1 has been recently characterizedHaverford, Pennsylvania 19041
(Sauer et al., 2001). Following TCR engagement, the7 Molecular Biology Graduate Program
ZAP-70 PTK becomes activated, resulting in phosphory-University of Iowa
lation of several substrates, including SLP-76 and the8 Department of Internal Medicine
raft-associated transmembrane adaptor protein LinkerUniversity of Iowa College of Medicine
for Activated T cells (LAT) (Zhang et al., 1998). TyrosineIowa City, Iowa 52242
phosphorylation of SLP-76 enables its interactions with
the SH2 domains of the Rac/Rho guanine nucleotide
exchange factor, Vav (Fang and Koretzky, 1999; RaabSummary
et al., 1997); the adaptor protein, Nck (Bubeck War-
denburg et al., 1998); and the Tec-family PTK, Itk (Bun-The hematopoietic cell-specific adaptor protein,
nell et al., 2000; Su et al., 1999). In addition, the SH2SLP-76, is critical for T cell development and mature
domain of Gads associates with phosphorylated LATT cell receptor (TCR) signaling; however, the structural
(Asada et al., 1999; Law et al., 1999; Liu et al., 1999),requirements of SLP-76 for mediating thymopoiesis
thereby recruiting SLP-76 and its associated moleculesand mature T cell function remain largely unknown. In
into lipid rafts.this study, transgenic mice were generated to examine
Mutant Jurkat T cell lines deficient in either SLP-76the requirements for specific domains of SLP-76 in
or LAT exhibit defects in TCR-induced ERK activation,thymocytes and peripheral T cells in vivo. Examination
PLC1 phosphorylation, and calcium influx, resulting inof mice expressing various mutants of SLP-76 on the
an inability to activate IL-2 NFAT/AP-1 promoter activitynull background demonstrates a differential require-
(Finco et al., 1998; Yablonski et al., 1998; Zhang et al.,
ment for specific domains of SLP-76 in thymocytes
1999a). In addition, mice deficient in SLP-76 or LAT
and T cells and provides new insight into the molecular demonstrate a complete block in thymocyte develop-
mechanisms underlying SLP-76 function. ment at the CD4CD8DN stage (Clements et al., 1998b;
Pivniouk et al., 1998; Zhang et al., 1999b), likely resulting
Introduction from defective signaling downstream of the pre-TCR.
Furthermore, a similar role for SLP-76 and LAT in trans-
Understanding how the pre-TCR and TCR direct matu- ducing signals downstream of syk-family PTKs has also
ration, selection, and activation events in thymocytes and been established in other hematopoietic cell types, in-
T cells has been an area of intense investigation. Although cluding platelets (Asazuma et al., 2000; Clements et al.,
these processes require common molecular pathways, 1999; Gross et al., 1999; Pasquet et al., 1999) and mast
precisely how these signals are integrated and trans- cells (Pivniouk et al., 1999; Saitoh et al., 2000). From
lated into distinct programs is not completely under- these and other data, it is suggested that SLP-76 and
stood. Adaptor proteins, which lack intrinsic enzymatic LAT associate to organize a multimolecular complex
activity, play an integral role in organizing molecular capable of modulating upstream TCR-induced signaling
events into productive signals required for the develop- events. Although studies have demonstrated an essen-
ment and function of diverse cell types. SH2 domain- tial role for SLP-76 in mediating T cell development and
containing leukocyte-specific phosphoprotein of 76 kDa TCR signaling, the structural requirements of SLP-76 for
regulating these events is not well understood. In Jurkat
T cells, overexpression of SLP-76 mutants in which one9Correspondence: koretzky@mail.med.upenn.edu
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Figure 1. Effects of SLP-76 Mutations on Thymocyte Development
(A) Schematic of SLP-76 and its associated proteins.
(B) Thymocytes obtained from 8- to 22-week-old SLP-76/ (inset), SLP-76/, and SLP-76/ mice reconstituted with WT, Y3F, 224-244, or
R448K SLP-76 transgenes were stained with anti-CD4 and anti-CD8. Percentages of positive cells within each quadrant are indicated. Average
thymocyte numbers for the various samples are indicated.
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of its three structural domains has been mutated results under the control of the CD2 promoter were generated
and crossed onto the SLP-76/ background. The CD2in an inability to augment TCR-induced IL-2 promoter
promoter/enhancer was used to direct transgene ex-activity, suggesting a required role for each domain in
pression in mature T cells as well as thymocytesmediating SLP-76 function in TCR-dependent signals
throughout all stages of development (Festenstein et(Fang et al., 1996; Musci et al., 1997b). However, these
al., 1996; Greaves et al., 1989; Hansal et al., 1998; Zhu-studies only allowed examination of SLP-76 mutants in
mabekov et al., 1995). SLP-76-deficient thymocytesthe presence of endogenous wild-type protein, and the
(transgene negative) show an accumulation of cells atmechanism underlying the function of each domain was
the DN stage, concordant with the developmental arrestunclear. More recently, expression of these SLP-76 mu-
previously observed (Figure 1B, inset) (Clements et al.,tants in SLP-76-deficient Jurkat T cells demonstrated
1998b; Pivniouk et al., 1998). SLP-76/ mice expressingpartial reconstitution by each mutant while also reveal-
a wild-type SLP-76 transgene (Figure 1B), show com-ing a newly defined role for additional sequences within
plete reconstitution of normal T cell development asthe proline-rich region of SLP-76 required for binding
measured by CD4/CD8 surface expression and thymicto PLC1 (Figure 1A and Yablonski et al., 2001). Although
cellularity (average  94 	 106 
 27.3 	 106 , n  7these studies have provided important insight into the
compared to SLP-76/: average  93 	 106 
 32.2 	mechanism underlying SLP-76 function, there remain
106 , n  10). These data demonstrate that the absencelimitations to cell line models. Indeed, studies have es-
of SLP-76 expression is responsible for the arrest intablished differences in the requirement for specific sig-
thymocyte development and serve as proof of principlenaling pathways between thymocytes and mature T cells
for subsequent SLP-76 structure-function studies.(Nishina et al., 1997; Schaeffer et al., 1999; Sun et al.,
In contrast to the complete rescue observed with wild-2000). Moreover, current systems have not allowed for
type SLP-76, transgenic expression of an SLP-76 mu-the investigation of differential requirements for distinct
tant bearing tyrosine-to-phenylalanine substitutions atdomains of SLP-76 in regulating thymopoiesis and pe-
Y112, Y128, and Y145 (Y3F) yields a marked defect inripheral T cell function in vivo. To address these issues,
thymic maturation as indicated by a significant accumu-we generated transgenic mice that use the CD2 pro-
lation of DN cells (15%–21% DN cells versus 1%–2%moter to express either wild-type or mutant transgenes
in the WT and SLP-76/ controls). In addition, totalof SLP-76 exclusively in the T lineage compartment (Fes-
thymocyte number is significantly reduced compared totenstein et al., 1996; Greaves et al., 1989; Hansal et al.,
control mice (average  10.1 	 106 
 5.0 	 106 , n 1998; Zhumabekov et al., 1995). These mice were mated
8). Those thymocytes that progress to the single-posi-onto a SLP-76-deficient background. In this report, we
tive (SP) stage are skewed toward the CD8 lineage. Micedemonstrate that, whereas wild-type SLP-76 rescues
expressing the SLP-76 224-244 mutant also exhibitT cell development and T cell function on the SLP-76/
significant abnormalities in both thymic cellularitybackground, a mutant of SLP-76 that cannot be tyrosine
(average  27.2 	 106 thymocytes 
 13.2 	 106 , n phosphorylated (Y3F) fails to yield normal thymopoiesis,
8) and in maturation (4%–5% DN cells), yet to a lesserrevealing defects both in the DN-to-DP transition and
degree than that observed in Y3F-expressing mice. Al-in selection. A second mutant of SLP-76 (224-244),
though the tyrosine residues and the Gads binding do-which cannot interact with Gads, demonstrates in-
main of SLP-76 appear to play critical roles in thymo-creased activity compared to the Y3F mutant but reveals
poiesis, expression of the SLP-76 R448K mutant isa role for this region in mediating optimal SLP-76 func-
sufficient to reconstitute nearly normal thymic cellularitytion in thymopoiesis and T cell function. Interestingly,
(average  83 	 106 
 3 	 106 , n  4) and CD4/CD8mice expressing a mutation of SLP-76 in its SH2 domain
surface profiles similar to those observed in SLP-76/exhibit nearly normal thymocyte development while dis-
littermate or transgenic SLP-76 WT-expressing mice,
playing significant defects in mature T cell function. Col-
indicating that thymopoiesis can occur independently
lectively, these data establish that there is a differential
of the SLP-76 SH2 domain. Failure to reconstitute thy-
requirement for SLP-76 domains in the regulation of mocyte development in Y3F- and 224-244-expressing
T cell development and function. thymocytes is not the consequence of insufficient ex-
pression of the transgenes. Similar expression levels of
Results each transgene are shown by Western blot analysis of
total thymocyte lysates (Figure 1C) and by intracellular
The Amino-Terminal Tyrosines of SLP-76 staining for SLP-76 protein within specific thymocyte
Are Essential for Thymocyte Development populations (Figure 1D).
To define the structural requirements for specific do- Markers for thymocyte development were character-
mains of SLP-76 in thymocyte development in vivo, ized further by examination of the DN populations for
levels of CD44 and CD25 (reviewed in von Boehmer ettransgenic mice expressing various forms of SLP-76
(C) Lysates from 2 	 106 thymocytes were immunoblotted for SLP-76. The 224-244 mutant migrates slightly faster by SDS-PAGE.
(D) CD4/CD8 double-negative (DN) and CD4/CD8 double-positive (DP) cells were analyzed for levels of intracellular SLP-76 by a combination
of surface and intracellular staining. Isotype control antibody staining (dotted line); anti-murine SLP-76 staining (solid line). Mean fluorescence
intensities (MFIs) of SLP-76 expression are indicated. Intracellular SLP-76 staining shown for / R448K thymocytes and in SLP-76/
littermate control thymocytes was done in a separate experiment.




Figure 2. Defective Upregulation of TCR and CD69 in Y3F-Expressing Thymocytes
(A) Thymocytes from SLP-76/ mice and SLP-76/ mice expressing the indicated transgenes were stained with anti-CD4 and anti-CD8.
CD4/CD8 double-positive (DP) or CD4 single-positive (SP) thymocytes were analyzed for both TCR (top panel) and CD69 (bottom panel)
expression. Percentages of positive staining cells are indicated.
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al., 1999). SLP-76-deficient mice demonstrate a com- despite comparable levels of TCR and CD3 expression
by all mice at the DP stage (Figure 2A and data notplete block in development at the pro-T3 (CD44-CD25)
stage (Figure 1E) (Clements et al., 1998b; Pivniouk et shown), DP thymocytes from SLP-76 Y3F mice demon-
strate a severely attenuated response to anti-TCR stimu-al., 1998), a period when pre-TCR signaling directs
expansion of the developing cells and their transition to lation as revealed by both CD69 and CD5 markers, indi-
cating significant defects in TCR-dependent signalingthe CD44CD25 stage. As shown, expression of the
SLP-76 WT transgene restores normal progression of required for selection.
Based upon the considerable reconstitution of thymicthymocyte development. In contrast, both the SLP-76
Y3F- and SLP-76224-244-expressing mutants demon- cellularity and CD4/CD8 surface indicators of thymocyte
development, it appears that the Gads binding domainstrate an accumulation of cells at the pro-T3 stage, sug-
gesting that pre-TCR signaling events at this checkpoint of SLP-76 may not be absolutely required for thymo-
poiesis but rather optimizes coupling of signaling path-are not overcome completely. Expression of the SLP-76
R448K mutant also fails to relieve the block at the pro- ways to pre-TCR and TCR stimulation. Accordingly,
DP thymocytes expressing the 224-244 mutant ofT3 stage entirely, indicating that the R448K mutant does
not function as well as WT SLP-76 in mediating pre- SLP-76 show a reduced response to TCR stimulation,
although greater than that shown by Y3F-expressingTCR signals. However, in contrast to the Y3F- and224-
244-expressing mutants, the SLP-76 R448K transgene thymocytes. DP thymocytes expressing the R448K mu-
tant upregulate both CD5 and CD69 to levels nearlyis still effective at directing efficient differentiation and
expansion of DP thymocytes. equivalent to those induced by control DP thymocytes.
To begin to elucidate biochemical events that may account
for the observed phenotype in transgene-expressingStructural Features of SLP-76 Required
for Thymocyte Selection thymocytes, we next examined TCR-induced tyrosine
phosphorylation events in thymocytes from control andAs DP thymocytes undergo positive selection in response
to signaling through the mature TCR, TCR/CD3 and transgenic mice. TCR stimulation of thymocytes ex-
pressing each of the SLP-76 constructs stimulated PTKCD69 expression become upregulated. As an initial
means to examine thymic selection, DP and CD4 SP activity as indicated by the inducible phosphorylation
of several proteins (Figure 3A), including a 38 kDathymocytes from wild-type and mutant transgenic mice
were assessed for TCR and CD69 surface expression protein (solid arrow), which presumably corresponds to
LAT. Interestingly, however, several bands were absent(Figure 2A). In both SLP-76/ and SLP-76 WT mice,
CD69 and TCR expression is upregulated upon transi- in lysates of cells from mice reconstituted with the Y3F
mutant including a protein of 76 kDa, likely SLP-76, andtion to the CD4 SP stage. In contrast, SLP-76 Y3F
thymocytes show decreased TCR and CD69 expres- a molecule with an apparent molecular mass of95 kDa,
a location which corresponds to Vav (broken arrows).sion at both the DP and CD4 SP stages, suggestive of
a requirement for SLP-76 tyrosine phosphorylation in Lysates from 224-244 thymocytes show weak phos-
phorylation of a band migrating slightly faster than 76signaling events at the DP stage. Thymocytes from the
SLP-76 224-244 mice demonstrate a considerable in- kDa (curved arrow), which likely represents the SLP-76
224-244 mutant. This band is reproducibly hypophos-crease in surface expression of both markers at the SP
stage, however to decreased levels as compared to phorylated in TCR-stimulated lysates, suggesting that
association of SLP-76 with Gads, and hence LAT, maySLP-76 WT and SLP-76/ thymocytes, consistent with
suboptimal signaling through the TCR in DP thymocytes. be required for optimal SLP-76 phosphorylation. Vav1
and SLP-76 have been shown to functionally cooperateSLP-76 R448K DP and CD4SP thymocytes exhibit both
CD69 and TCR expression levels similar to those of in TCR signaling pathways (Fang and Koretzky, 1999;
Raab et al., 1997; Wu et al., 1996). In particular, tyrosinecontrol and SLP-76 WT thymocytes, again suggesting
that the SH2 domain of SLP-76 plays a less critical role phosphorylation of SLP-76 has been implicated in regu-
lating TCR-induced actin rearrangements through itsthan the amino-terminal tyrosines and Gads binding do-
main in thymocyte selection. In all mice examined, simi- association with Vav1 and Nck (Bubeck Wardenburg et
al., 1998). Additionally, the gross phenotype of thymo-lar findings were also observed in CD8 SP thymocytes
(data not shown). Signaling through the TCR at the cytes from Vav1/ (Fischer et al., 1998; Holsinger et al.,
1998) and Vav1//Vav2/ (Tedford et al., 2001) miceDP stage was also evaluated ex vivo by stimulating
enriched DP thymocyte populations with plate-bound resembles that of SLP-76/Y3F transgenic thymocytes.
Since Vav1 has been shown to play a critical role in activa-anti-TCR antibodies to mimic phenotypic changes con-
sistent with positive selection (Cibotti et al., 1997; tion-induced TCR clustering (Fischer et al., 1998; Holsinger
et al., 1998), we assessed the requirement for SLP-76Groves et al., 1995; Kearse et al., 1995). Following 18–20
hr of stimulation, thymocytes were stained for the mark- domains in ligand-induced TCR clustering in thymocytes.
Thymocytes from control and transgene-expressing miceers of selection, CD5 and CD69. As expected, thymo-
cytes from SLP-76 WT transgenic and control SLP-76/ were stimulated with anti-CD3 and analyzed for TCR
clustering by fluorescence microscopy (Figure 3B).mice exhibit substantial upregulation of both CD5 and
CD69 following TCR stimulation (Figure 2B). However, Samples were also quantitatively indexed for levels of
(B) Thymocytes enriched for DP cells from each mouse were cultured in either medium alone (unstimulated) or with plate-bound anti-TCR,
then analyzed for the activation markers, CD5 (top panels) and CD69 (bottom panel). For CD69 results, clear histograms represent unstimulated
cells, and filled histograms represent CD69 expression following anti-TCR stimulation. Percentages of positive cells are indicated.
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Figure 3. SLP-76 Y3F Thymocytes Signal via Their TCR but Fail to Induce CD3-Induced Receptor Clustering
(A) Thymocytes from SLP-76/ or SLP-76/ mice expressing the indicated transgenes were either left unstimulated (Un) or stimulated with
anti-CD3 (500A2) for the indicated times. Whole-cell lysates were resolved by SDS/PAGE, and tyrosine-phosphorylated proteins were detected
with anti-phosphotyrosine monoclonal antibody (4G10). Molecular weight markers are indicated. Broken arrows indicate bands that are
hypophosphorylated in Y3F-expressing thymocytes. The solid arrow at 38 kDa indicates a phosphorylated band that is presumed to
correspond to phospho-LAT. The small curved arrow in the / 224-244 panel indicates a tyrosine-phosphorylated band that likely corre-
sponds to the mutant SLP-76, which migrates slightly faster than wild-type.
(B) Thymocytes from SLP-76/ (panel A), SLP-76/ WT (panel C), SLP-76/ Y3F (panel D), SLP-76/ 224-244 (panel E), and SLP-76/
R448K (panel F) mice were evaluated for TCR clustering. Panel B shows SLP-76/ thymocytes stimulated in the presence of the actin
polymerization inhibitor, cytochalasin D. Representative fields from each sample in one experiment are depicted at a magnification of 1000	.
(C) Quantitative measurements of CD3 clustering were determined by index measurements of fluorescence intensity. Results are reported
as percent increase in clustering indices over that obtained for cells fixed prior to addition of crosslinking antibody. Cytochalasin D, Cyt D.
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Figure 4. Effects of SLP-76 Mutations on Peripheral T Cell Populations
(A) Splenocytes from SLP-76/ or SLP-76/ mice expressing the WT, Y3F, 224-244, or R448K transgenes were either left unstimulated,
stimulated with anti-CD3 for 5 min, or treated with pervanadate (PV). Lysates were subjected to immunoprecipitation with anti-SLP-76
antiserum followed by immunoblot detection for Gads (bottom) or SLP-76 (top). Note that the 224-244 mutant migrates slightly faster than
WT SLP-76 or the other SLP-76 mutants. The association between SLP-76 and Gads is constitutive and is not affected by TCR or PV
stimulation.
(B) Splenocytes were stained for CD3 (histograms) or for CD4 and CD8 (bottom plots) and analyzed by flow cytometry. Percentages of
positive cells are indicated.
TCR clustering by measuring the degree of deviation in points during thymopoiesis, implying that the associa-
tion with Gads may function to regulate optimal progres-fluorescence intensity normalized to the average fluo-
rescence intensity of the cell (Figure 3C). In contrast to sion throughout development. In contrast to the Y3F and
224-244 mutants, mutation of the SLP-76 SH2 domainefficient TCR clustering exhibited by wild-type (Figure
3B, panel A) and SLP-76 WT transgenic thymocytes permits near normal reconstitution of thymic cellularity,
CD4/CD8 surface marker profiles, and expression of(panel C), Y3F-expressing thymocytes (panel D) show
defects in TCR clustering similar to that seen when wild- markers associated with thymic selection events.
type thymocytes are treated with cytochalasin D (panel
B), an inhibitor of actin polymerization. Thymocytes from Peripheral T Cell Function in
SLP-76-Reconstituted Micethe 224-244 and R448K transgenic thymocytes display
TCR clustering that is similar to that seen with control Despite defects in thymocyte development exhibited
by the Y3F- and 224-244-expressing mice, all micethymocytes (panels E and F, respectively). Collectively,
these data suggest that tyrosine phosphorylation of revealed the presence of mature splenic T cells. To study
the effects of SLP-76 domains in mature T cells, splenicSLP-76 plays a critical role in mediating both pre-TCR-
andTCR-dependent selection events during thymocyte T cells were isolated and examined for TCR-dependent
responses. All mice express transgenic SLP-76 at levelsmaturation. Examination of TCR-mediated receptor clus-
tering suggests that phosphorylation of SLP-76 functions similar to endogenous protein (Figure 4A). T cell-specific
transgene expression was confirmed by intracellular stain-in promoting actin rearrangements during thymopoiesis,
which may relate to a functional association between ing or Western blot confirming the absence of SLP-76
protein in macrophages, platelets, and B cells (data notSLP-76 and Vav. Mutation of the Gads binding domain
of SLP-76 results in less severe defects at both check- shown). Consistent with this, all transgenic mice main-
Immunity
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Figure 6. Y3F-Expressing T Cells Fail to Induce Protein Tyrosine Kinase Activity in Response to TCR Engagement
Purified T cells were left unstimulated or stimulated with soluble anti-CD3 (500A2) for the indicated times. Cleared whole-cell lysates were
resolved by SDS/PAGE. Tyrosine-phosphorylated proteins were detected using anti-phosphotyrosine antibody (4G10). Protein molecular weight
markers are indicated. The curved arrow in the/ 224-244 panel indicates the phosphorylated band that presumably corresponds to the mutant
SLP-76 protein. Arrowheads indicate observed tyrosine phosphorylated bands at 76 kDa (likely SLP-76) and at 38 kDa (likely LAT).
tained a similar bleeding diathesis to that observed in TCR engagement. T cells from both the 224-244 and
the R448K mutant mice demonstrate significantly com-SLP-76/ mice as reported (Clements et al., 1999). As
expected, the SLP-76 Y3F mutant protein cannot be ty- promised TCR-mediated upregulation of CD25 and
CD69 but respond better than cells from Y3F-reconstitu-rosine phosphorylated even following stimulation with
the phosphatase inhibitor, pervanadate (data not shown). ted mice. Treatment of splenocytes from all transgenic
mice with the phorbol ester results in upregulation of bothAdditionally, whereas the Y3F and R448K mutants con-
stitutively associate with Gads, the 224-244 mutant activation markers to levels similar to control SLP-76/
splenocytes (data not shown). The requirement forfails to do so (Figure 4A, lanes 10–12).
T cells from SLP-76/ Y3F transgenic mice show SLP-76 domains in mediating TCR-induced T cell prolifer-
ation was also examined. Purified T cells from SLP-76/considerable numbers of CD3-positive T cells, although
expression of the TCR is diminished (Figure 4B). More and transgenic mice were stimulated with varying con-
centrations of anti-CD3 in the presence of irradiatednormal levels of TCR are found in mice expressing the
224-244 and R448K mutants. Upon examination of wild-type splenocytes. T cells from mice reconstituted
with the WT transgene proliferate in response to anti-CD4 and CD8 populations (Figure 4B), all mutant
transgenic mice demonstrate a CD4:CD8 ratio that is CD3 stimulation as well as control splenic T cells (Figure
5B, left panel). In contrast, splenic T cells from the Y3Fskewed toward the CD8 lineage compared to SLP-76
WT transgenic and control mice. We find this particularly transgenic mice fail to proliferate at any concentration
of anti-CD3 tested. Peripheral T cells expressing theinteresting in light of the fact that the CD4:CD8 skewing
in the thymus is more pronounced in the Y3F-expressing Gads binding mutant demonstrate a significantly dimin-
ished, albeit variable proliferative response to anti-CD3mice. This disparity suggests that there exist differential
requirements for SLP-76 domains in the thymus versus stimulation, ranging from intermediate to severe defects
(i.e., the fold increase in proliferation ranges between 5%the periphery. Splenocytes from transgenic and SLP-76/
mice were next analyzed for TCR-induced upregulation and 15% of that displayed by SLP-76/ splenocytes).
Surprisingly, splenic T cells from SLP-76 R448K miceof CD25 and CD69 following TCR stimulation. Whereas
both control SLP-76/ and SLP-76 WT transgenic mice also show a striking defect in proliferation at all concen-
trations of anti-CD3. Stimulation with anti-CD28 anti-upregulate these activation antigens following treatment
with anti-CD3 (Figure 5A), T cells expressing the Y3F mu- bodies does not correct the T cell proliferative deficits
in any of the mutant transgenic mice (data not shown);tant completely fail to upregulate either marker following
Figure 5. SLP-76 Structural Requirements for Peripheral T Cell Function
(A) Splenocytes were either left unstimulated (clear histograms) or stimulated with anti-CD3 (filled histograms) followed by analysis of CD25
and CD69 surface expression. Results are shown for Thy1.2  gated cells.
(B) Purified T cells were cultured in the presence of irradiated wild-type splenocytes in either medium alone or medium containing the indicated
concentrations of anti-CD3 without exogenous IL-2 (left bar graph) or with recombinant IL-2 (right panel, line graph) for 48 hr. During the last
12 hr of culture, cells were pulsed with 1 Ci/well of 3 [H]-thymidine prior to measurement of 3 [H]-thymidine incorporation.
(C) For BrdU experiments, splenocytes were either left unstimulated or stimulated with anti-CD3. Cells were labeled with BrdU after 42 hr of
culture followed by cell cycle analysis with 7-AAD and anti-BrdU antibody. Data represent cell cycle profiles of gated CD4- and CD8-positive
T cells. Percentages of T cells in S phase are indicated.
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Figure 7. Effects of SLP-76 Mutations on TCR-Mediated PLC1 Phosphorylation and Calcium Influx
(A) Splenocytes were either left unstimulated or stimulated with anti-CD3 . Cellular lysates were subjected to immunoprecipitation using anti-
PLC1 followed by detection with anti-phosphotyrosine (anti-pY) antibody. Western blots were then reprobed with anti-PLC1 antibody.
Results from the / R448K and its littermate SLP-76/ control are from a separate experiment.
(B) Splenocytes from the indicated mice were stained with biotin-anti-CD3. Calcium signaling was initiated by addition of streptavidin (arrows).
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however, T cells from all mice demonstrate a robust induction of PLC1 phosphorylation at any time point
(lanes 7–9), while T cells expressing the 224-244 mu-response to stimulation with PMA plus Ionomycin (data
tant show only a poor but reproducible induction ofnot shown).
PLC1 phosphorylation (lanes 10–12). Interestingly, in-Both 224-244 and R448K mutant transgenic T cells
activation of the SH2 domain of SLP-76 results in induc-show a diminished ability to upregulate IL-2R following
tion of PLC1 phosphorylation similar to wild-type con-TCR stimulation compared to control T cells (Figure 5A).
trol mice at both time points of stimulation (lanes 13–18).Consistent with this, addition of exogenous IL-2 only
Concordant with the PLC1 phosphorylation studies,partially restores their proliferative defect at lower con-
the SLP-76 WT transgenic T cells show robust TCR-centrations of anti-CD3 (Figure 5B, right panel). How-
induced elevations in cytoplasmic calcium (Figure 7B).ever, at high doses of TCR stimulation, both mutant
T cells expressing the R448K mutation also show effi-transgenic T cells proliferate similarly to control cells,
cient TCR-mediated rises in intracellular calcium. Assuggesting that the observed defects in proliferation are
expected, T cells from Y3F transgenic mice exhibit nonot due to defective signaling through the IL-2 receptor
measurable change in cytoplasmic calcium followingbut rather are due to defects in IL-2 production and/
TCR stimulation. In agreement with the decreasedor IL-2R upregulation. As expected, Y3F-expressing
PLC1 phosphorylation, mutation of the Gads bindingT cells, which fail to upregulate CD25 following TCR
domain of SLP-76 results in a diminution in the peakstimulation, also do not proliferate even with exogenous
elevation in cytoplasmic calcium measured.IL-2 added. To determine if the proliferative defects ob-
Reconstitution studies performed in LAT-deficientserved in T cells expressing mutant SLP-76 transgenes
Jurkat T cells suggest that recruitment of a Gads-SLP-76are due to a failure to enter cell cycle following TCR
complex to LAT is required for optimal association be-stimulation or an arrest in a specific phase, TCR-induced
tween PLC1 and LAT following TCR stimulation (Lincell cycle profiles were assessed by BrdU labeling and
and Weiss, 2001; Zhang et al., 2000). To determine if7-AAD analysis. In contrast to SLP-76/and WT control
binding of SLP-76 to LAT is required for stable complexT cells, mutant transgenic T cells demonstrate defective
formation between PLC1 and LAT, PLC1 was immu-entry into the cell cycle as indicated by percentages of
noprecipitated from wild-type, Y3F, and224-244 trans-T cells in S phase (Figure 5C).
genic T cells. Following TCR or pervanadate stimulation
of wild-type T cells, phosphorylated LAT can be ob-
Proximal Signaling via the TCR in SLP-76 served in PLC1 immune complexes (Figure 7C, lanes
Transgenic T Cells 2–4). Consistent with an inability to induce tyrosine
Previous studies in T cell lines implicate a requirement phosphorylation events in Y3F-expressing T cells, there
for SLP-76 in coupling TCR engagement to early signal- is an absence of PLC1-associated phosphorylated LAT
ing events, in particular, PLC1 phosphorylation and in TCR-stimulated lanes (lanes 6–7). However, when
ERK activation (Yablonski et al., 1998). To correlate the cells are treated with pervanadate to bypass the TCR,
functional defects observed in the mutant transgenic a band corresponding to phosphorylated LAT can be
with deficits in specific signaling pathways, splenic readily detected in PLC1 immunoprecipitates (lane 8).
T cells were analyzed for their ability to activate various Interestingly, although TCR-stimulated whole-cell ly-
molecular events following TCR stimulation. First, puri- sates from 224-244-expressing T cells demonstrate
fied T cells from control and transgenic mice were stimu- efficient tyrosine phosphorylation of several proteins,
lated with anti-CD3 and assessed for tyrosine phos- including LAT, the amount of LAT present in PLC1
phorylation of cellular proteins (Figure 6). In contrast to immune complexes is diminished in both TCR- and per-
all other transgene-expressing mice, T cells from Y3F vanadate-stimulated conditions (lanes 10–12) despite
mutant transgenic mice fail to induce detectable tyro- equivalent amounts of PLC1 precipitated from each
sine phosphorylation following TCR stimulation, which sample. It should be noted that in some experiments,
is presumably due to the low levels of TCR surface a band corresponding to phosphorylated LAT can be
expression. In contrast, both the 224-244 and R448K detected in pervanadate-stimulated PLC1 immunopre-
transgenic T cells induce tyrosine phosphorylation of cipitates from 224-244-expressing T cells; however,
several proteins similar to control T cells. the amount is consistently less than that observed from
Tyrosine phosphorylation of PLC1 results in its acti- wild-type or WT transgenic T cells stimulated with either
vation and generation of second messengers, yielding anti-CD3 or pervanadate. These findings suggest that
rises in free cytoplasmic calcium and PKC activation. SLP-76 may be required, via its inducible binding to
As shown in Figure 7A (lanes 1–6), PLC1 is inducibly LAT mediated through Gads, to stabilize the interaction
phosphorylated in both SLP-76/ and SLP-76 WT between PLC1 and LAT. This is consistent with a con-
transgenic splenocytes following CD3 engagement. In stitutive interaction between SLP-76 and PLC1 inde-
pendent of the Gads binding domain of SLP-76, firstcontrast, Y3F-expressing splenocytes demonstrate no
Curves represent averaging of signals from at least 30 individual cells.
(C) Splenocytes from the indicated mice were left unstimulated, stimulated with anti-CD3 for 3 or 10 min, or treated with pervanadate (top
panel). PLC1 was immunoprecipitated from lysates, and Western blots were probed with anti-phosphotyrosine antibody. The phosphorylated
band of 38 kDa, corresponding to LAT, is shown in the middle panel. The bottom blot is a reprobe of the stripped blot to show equal
amounts of PLC1 in each lane. In the bottom panel, anti-SLP-76 immunoprecipitates from lysates of unstimulated purified T cells were
resolved by SDS/PAGE. The top portion of the blot was immunoblotted for PLC1, while the bottom portion was probed for SLP-76. 224-
244, 20; R448K, R/K.
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shown in Jurkat cells (Yablonski et al., 2001) and demon- ies performed in Jurkat cells suggest that SLP-76 is not
required for Vav phosphorylation; however, we find thatstrated (Figure 7C, bottom panel) in primary T cells.
Y3F-expressing thymocytes fail to efficiently phosphor-
ylate a band that migrates at 95 kDa. Although weDiscussion
have not conclusively identified this hypophosphory-
lated band as Vav1, there are many gross similaritiesPrevious experiments in Jurkat cells showed a require-
between Vav1-deficient mice and mice expressing thement for SLP-76 in mediating TCR-dependent signals
Y3F SLP-76 transgene, including a relative block in thy-(Yablonski et al., 1998), and in vivo studies also revealed
mopoiesis at both the DN and DP stages as well asa critical role for this adaptor in directing thymocyte
markedly decreased thymic cellularity (Fischer et al.,development (Clements et al., 1998b; Pivniouk et al.,
1998). Furthermore, similar to Vav1-deficient thymo-1998). Although overexpression studies have suggested
cytes, Y3F-expressing thymocytes exhibit defects in li-a required role for each domain of SLP-76 in activating
gand-dependent TCR clustering. Thus, it is possible thatIL-2 NF-AT promoter activity (Fang et al., 1996; Musci
SLP-76 cooperates with Vav in mediating TCR-depen-et al., 1997b), until now in vivo evidence demonstrating
dent actin reorganization downstream of Vav phosphor-the function of these domains has been lacking. Addi-
ylation. It is also possible that SLP-76 modulates othertionally, these previous studies precluded investigation
Vav-regulated functions. While Vav1 is required for TCR-into the role of SLP-76 domains in thymocyte develop-
dependent actin polarization leading to calcium influx,ment or the requirement for each domain in thymocytes
IL-2 production, and T cell proliferation (Fischer et al.,versus mature T cells. By utilizing transgenic mice ex-
1998; Holsinger et al., 1998), it has been shown thatpressing either wild-type or mutant SLP-76, we now
these functions may not be entirely confined to its GEFdemonstrate a differential requirement for SLP-76 do-
activity for rho-family GTPases (Krawczyk et al., 2000).mains in mediating thymopoiesis and activation of ma-
Interestingly, Manetz et al. have demonstrated a require-ture T cells in vivo. Additionally, since the CD2 promoter/
ment for Vav1 in FcR1-driven PLC1/2 phosphorylationenhancer directs T lineage-specific expression, results
(Manetz et al., 2001). Thus, it is possible that SLP-76 andfrom mice expressing the wild-type SLP-76 (SLP-76 WT)
Vav1 functionally cooperate to promote TCR-mediatedtransgene confirm that the T cell defect observed in
PLC1 activation and calcium influx through effectorSLP-76/ mice is T cell autonomous.
molecules other than rho-family GTPases.We and others have shown previously that SLP-76/
Our data demonstrate that the Gads binding regionthymocytes exhibit a complete developmental arrest at
of SLP-76, although less critical than the tyrosines, isthe CD25CD44 pro-T3 stage when signals from the
still necessary for optimal TCR and pre-TCR function.pre-TCR are activated to promote thymocyte prolifera-
One explanation for this is that Gads mediates an induc-tion and TCR allelic exclusion (Aifantis et al., 1999;
ible interaction between SLP-76 and the transmembraneClements et al., 1998b; Pivniouk et al., 1998). To deter-
adaptor, LAT (Aifantis et al., 1999; Law et al., 1999; Liu etmine the importance of SLP-76 phosphorylation, tyro-
al., 1999; Yoder et al., 2001). Significantly, the phenotypesine residues Y112, Y128, and Y145 were mutated to
observed in Gads-deficient mice (Yoder et al., 2001), as
phenylalanine. Mutation of these residues results in se-
well as transgenic mice expressing a dominant-negative
vere defects in thymocyte development. Previous stud-
mutant of Gads lacking a functional SH2 domain (Kikuchi
ies have shown that reconstitution of SLP-76 deficient
et al., 2001), resembles the thymocyte and T cell defects
Jurkat T cells with the Y3F mutant fails to restore normal observed in SLP-76 null mice expressing the 224-244
TCR-mediated ERK activation, PLC1 phosphorylation, mutant, supportive of a functional role underlying the
and IP3 production (Yablonski et al., 2001). As expres- SLP-76/Gads/LAT complex. It is possible that the resid-
sion of constitutively active or dominant-negative forms ual signaling seen in these mice results from an associa-
of members of the Ras/MAPK pathway in thymocytes tion between SLP-76 and LAT independent of Gads, or
indicate an important role for ERK in mediating the differ- alternatively that SLP-76 can be recruited to lipid rafts
entiation and expansion of DP thymocytes (Crompton through yet other interactions.
et al., 1996; Iritani et al., 1999; Swat et al., 1996), we Recent evidence has shown a constitutive interaction
speculate that the SLP-76 Y3F mutant leads to inefficient between a proline-rich region of SLP-76 and the SH3
or more transient ERK activation at the DN stage, yield- domain of PLC1 that is independent of the Gads bind-
ing poor differentiation and expansion of DP cells. De- ing domain and is critical for SLP-76 function in TCR-
spite this relative block, some cells still progress to the mediated signaling pathways (Yablonski et al., 2001). It
DP stage, indicating that other domains of SLP-76 are is speculated that through this association, SLP-76 may
sufficient to mediate limited pre-TCR-induced signals. help recruit PLC1 to LAT or to stabilize the interaction,
However, DP thymocytes expressing the Y3F mutant of which may be required for optimal PLC1 phosphoryla-
SLP-76 still exhibit severe defects in selection. Of tion. In fact, our data with cells expressing the 224-
course, a comprehensive analysis of the impact of 244 mutant of SLP-76 suggest that if SLP-76 cannot
SLP-76 domains on thymocyte signaling leading to se- be recruited to LAT, the association between LAT and
lection abnormalities will require studies utilizing TCR PLC1 is compromised. This is true even following per-
transgenic mice. vanadate stimulation, which should maximally phos-
Following TCR ligation, SLP-76 becomes tyrosine phorylate both proteins. Thus, one potential function of
phosphorylated by ZAP-70, resulting in its association SLP-76 may be to stabilize the recruitment of PLC1 to
with Vav, Nck, and Itk (Bubeck Wardenburg et al., 1998; LAT where it can then interact with lipid raft-associated
Bunnell et al., 2000; Fang and Koretzky, 1999; Raab et substrates. This may occur via the direct interaction
between SLP-76 and PLC1 or via changes in conforma-al., 1997; Su et al., 1999; Wardenburg et al., 1996). Stud-
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croinjection into fertilized mouse embryos derived from an F2 crosstion of either LAT or PLC1, optimizing their association.
of C57BL/6J 	 SJL/J (B6SJL) at the University of Iowa TransgenicWe must note, however, that an alternative explanation
Animal Facility. Animals for the transgenic SLP-76 constructs werefor the phenotype of the 224-244-expressing cells is
then backcrossed onto the SLP-76 null background.
that this mutant sequesters PLC1 from LAT.
Surprisingly, inactivation of the SLP-76 SH2 domain Flow Cytometry
reveals a differential requirement for this domain in me- Expression of cell surface antigens was examined by standard flow
cytometric methods. Antibodies used were anti-CD3-FITC or -PE,diating thymocyte development versus mature T cell
anti-CD69-biotin or -PE, anti-CD4-APC or -PE, anti-CD8-FITC orfunction. SLP-76/ mice expressing the SLP-76 R448K
-PE, anti-CD25-FITC, anti-CD44-CyChrome, anti-CD5-FITC, anti-mutant manifest nearly normal thymopoiesis as mea-
Thy1.2-APC, and anti-TCR-CyChrome (all from Pharmingen, Lasured by cellularity, CD4/CD8 surface profiles, and
Jolla, CA). Biotinylated antibodies were detected with streptavidin-
upregulation of activation markers following TCR en- APC (Pharmingen, La Jolla, CA). To detect intracellular SLP-76, cells
gagement. In contrast, splenic T cells from these mice were fixed and permeablized using the Cytofix/Cytoperm kit (Becton
Dickinson, La Jolla, CA) according to manufacturer’s directions.demonstrate significantly compromised TCR-depen-
Cells were then stained using either a purified PE-conjugated anti-dent proliferation and upregulation of CD25 and CD69
murine SLP-76 antibody (Clements et al., 1998a) or a PE-labeledactivation markers. However, SLP-76 R448K T cells ex-
goat IgG control antibody (Caltag Laboratories, Burlingame, CA).hibit normal PLC1 phosphorylation, calcium signaling,
For analysis of thymocyte apoptosis, cells were stained with 7-AAD
and ERK activation following TCR ligation, suggesting (Molecular Probes, Eugene, OR).
that the SH2 domain of SLP-76 does not function up-
stream of these effector pathways. In Vitro Proliferation Assays
Purified T cells were cultured in 96-well plates at 4 	 104 /well withThe SH2 domain of SLP-76 associates with ADAP
5 	 105 irradiated splenocytes from wild-type littermate controls infollowing TCR-stimulated ADAP phosphorylation (da
triplicate with either medium alone (IMDM supplemented with 10%Silva et al., 1997; Musci et al., 1997a). Recent studies
FBS, 105 -mercaptoethanol, penicillin, streptomycin, and gluta-
of ADAP-deficient mice (Peterson et al., 2001; Griffiths mine), medium containing the indicated concentrations of soluble
et al., 2001) reveal a critical role for ADAP in TCR-depen- anti-CD3 (2C11, Pharmingen, La Jolla, CA) with or without 40 units/
dent “inside-out” signaling to integrins. Similar to ml exogenous rhIL-2, or media containing 12.5 ng/ml PMA (Sigma,
St. Louis, MO) plus 100 ng/ml ionomycin (Sigma, St. Louis, MO) forR448K-expressing T cells, ADAP/ T cells show severe
72 hr. Cells were pulsed with 1 Ci/well 3 [H]-thymidine (ICN, Costadefects in TCR-mediated proliferation and upregulation
Mesa, CA) during the last 12 hr of culture. Cell cycle analysis wasof activation markers while demonstrating PLC1 phos-
performed on splenocytes cultured in either medium alone or me-
phorylation, calcium influx, and ERK activation similar dium containing 0.1 g/ml anti-CD3. Cells were pulsed with BrdU
to wild-type T cells following TCR engagement. These after 42 hr of culture, then analyzed for DNA content by 7-AAD
data support the possibility that the phenotype ob- staining and for incorporated BrdU with FITC-anti-BrdU.
served in the SLP-76 R448K mice may be attributed, at
Immunoprecipitations and Western Blotsleast in part, to a loss of SLP-76 association with ADAP
Splenocytes or purified T cells were either left unstimulated or stimu-in TCR-dependent functions.
lated with 5 g/ml anti-CD3 (500A2, Pharmingen, La Jolla, CA) atFinally, in addition to the three domains described in
37C for the indicated times or pervanadate (PV, 100M NaVO4, and
this study, it is becoming apparent that other binding 3 mM H2O2) at room temperature for 2 min. Lysates were resolved by
motifs in SLP-76 exist and may reveal additional path- SDS/PAGE for examination of all proteins or subjected to immuno-
ways or molecules regulated by SLP-76 in T cells and other precipitation using GammaBind (Pharmacia Biotech Inc., Uppsal,
Sweden) beads conjugated with either mixed monoclonal anti-hematopoietic cell types. SLP-76 is an adaptor protein
PLC1 antibody (Upstate Biotechnology, Lake Placid, NY) or poly-thought to function as a scaffold, recruiting several mole-
clonal anti-murine SLP-76 antibody. Precipitated proteins were re-cules into an active nucleation complex required for initi-
solved by SDS/PAGE and transferred to nitrocellulose followed by
ation of pre-TCR and TCR signaling. It is becoming more Western blot using the indicated antibodies. Anti-phosphotyrosine
evident that signaling pathways regulating thymocyte antibody (clone 4G10, Upstate Biotechnology, Lake Placid, NY) was
selection processes overlap with but differ from those used to detect tyrosine phosphorylated proteins.
regulating mature T cell activation. SLP-76, as well as
In Vitro Thymocyte Stimulationsother adaptor proteins such as LAT and Gads, may not
CD4CD8 thymocytes were purified by two rounds of positive pan-only play an important role in regulating distinct TCR
ning on petri plates coated with 1 g/ml anti-CD8 antibody (83-12-5)signaling pathways, but may also be critical for modulat-
in PBS containing 100 mM Na2CO3 (pH 8.5) (Nakayama et al., 1990).ing the strength and duration of signaling, thereby regu- For stimulations, 24-well plates were coated overnight in the presence
lating distinct outcomes. of 0.3 ml of a 10 ug/ml solution of purified anti-TCR (H57-597). Cells
were added at a density of 2 	 106 per well in a total of 0.5 ml
culture medium (RPMI, 10% FCS, l-glutamine, nonessential aminoExperimental Procedures
acids, sodium pyruvate, penicillin, streptomycin, and 5 	 105 M
2-mercaptoethanol), then cultured for 16–20 hr prior to analysis byGeneration of SLP-76 Transgenic Mice
flow cytometry.Wild-type murine SLP-76 cDNA was obtained from murine splenic
RNA by RT-PCR. The SLP-76 Y3F and R448K mutant cDNAs were
generated by overlap extension, using primers that created either TCR Clustering Assays
Purified T cells were settled onto glass coverslips for 30 min followedphenylalanine substitutions at amino acid residues Y112, Y128, and
Y145 for the Y3F mutation or a lysine substitution at amino acid residue by staining with 1 g/ml anti-CD3 (2C11, Pharmingen, La Jolla, CA)
at 37C in staining buffer (PBS, 1% BSA, 1% goat serum) for 30 min.R448 for the R448K mutation. The SLP-76224-244 mutant was gener-
ated by creating HindIII sites flanking amino acid residues 224-244 Cells were then washed in PBS and stimulated with 1 g/ml biotinyl-
ated goat anti-hamster antibody (Jackson ImmunoResearch, Westfollowed by a three-way ligation. Sequence fidelity of all cDNAs was
confirmed prior to subcloning into the EcoR1 and SalI sites of the Grove, PA) for 20 min at 37C. Stimulations were stopped by fixation in
3.7% formaldehyde. Cells were then stained with FITC-streptavidinCD2 promoter/enhancer provided by Dr. P. Love (National Institutes
of Health, Bethesda, MD). Transgenic mice were generated by mi- prior to analysis using a Nikon Eclipse E800 fluorescent microscope.
Immunity
1024
As control, wild-type T cells were either stimulated in the presence of schneider, L.R., and Mouchiroud, G. (1998). Mona, a novel hemato-
poietic-specific adaptor interacting with the macrophage colony-20 M cytochalasin D or were fixed prior to addition of crosslinking
secondary antibody. TCR clustering indices were determined by stimulating factor receptor, is implicated in monocyte/macrophage
development. EMBO J. 17, 7273–7281.dividing the standard deviation in fluorescence intensity over the cell
membrane by the average fluorescence intensity over the measured Bubeck Wardenburg, J., Pappu, R., Bu, J.Y., Mayer, B., Chernoff,
area using Metamorph Imaging software. At least 50 cells per sample J., Straus, D., and Chan, A.C. (1998). Regulation of PAK activation
were measured. Results are reported as percent increase in cluster- and the T cell cytoskeleton by the linker protein SLP-76. Immunity
ing index over that obtained for cells that were fixed prior to stimula- 9, 607–616.
tion with crosslinking antibody.
Bunnell, S.C., Diehn, M., Yaffe, M.B., Findell, P.R., Cantley, L.C., and
Berg, L.J. (2000). Biochemical interactions integrating Itk with the
Calcium Measurements
T cell receptor-initiated signaling cascade. J. Biol. Chem. 275, 2219–
Single-cell calcium video imaging was performed as described
2230.
(Freedman et al., 1999). In brief, cells were loaded with fura-2 AM
Cibotti, R., Punt, J.A., Dash, K.S., Sharrow, S.O., and Singer, A.(6.0 M; Molecular Probes, Eugene, OR) and concurrently labeled
(1997). Surface molecules that drive T cell development in vitro inwith biotin-conjugated anti-CD3 (2C11). Labeled cells were trans-
the absence of thymic epithelium and in the absence of lineage-ferred to a temperature-controlled microscope recording chamber
specific signals. Immunity 6, 245–255.(Brook Industries, Lake Villa, IL) and allowed to settle onto a Poly-
L-lysine (1 g/ml) coated glass coverslip chamber bottom. Signaling Clements, J.L., Ross-Barta, S.E., Tygrett, L.T., Waldschmidt, T.J.,
was initiated by adding streptavidin (1 g/ml, Jackson Immunore- and Koretzky, G.A. (1998a). SLP-76 expression is restricted to hemo-
search, West Grove, PA) to crosslink surface-bound biotin-conju- poietic cells of monocyte, granulocyte, and T lymphocyte lineage
gated mAb. Discrete bandwidth excitation light (340 
 10 nm, 380 
 and is regulated during T cell maturation and activation. J. Immunol.
10 nm) from a xenon source coupled to a computer-controlled 161, 3880–3889.
monochromator (TILL, Applied Scientific Imaging, OR) was directed Clements, J.L., Yang, B., Ross-Barta, S.E., Eliason, S.L., Hrstka,
to the epifluorescence attachment of an inverted fluorescence mi- R.F., Williamson, R.A., and Koretzky, G.A. (1998b). Requirement for
croscope (Nikon TE300, USA) through a quartz fiber optic guide. the leukocyte-specific adapter protein SLP-76 for normal T cell de-
Excitation light was directed through a fluorescence objective (40	 velopment. Science 281, 416–419.
or 100	, Nikon) via a dichroic mirror. The emitted fluorescence from
Clements, J.L., Lee, J.R., Gross, B., Yang, B., Olson, J.D., Sandra,fura-2 loaded cells passed through a 470 nm long pass filter, and
A., Watson, S.P., Lentz, S.R., and Koretzky, G.A. (1999). Fetal hemor-images were captured with an intensified charge coupled video
rhage and platelet dysfunction in SLP-76-deficient mice. J. Clin.camera (Hammamatsu Model C2400-68) connected to the side port
Invest. 103, 19–25.of the microscope using Metafluor imaging software (Universal Im-
Crompton, T., Gilmour, K.C., and Owen, M.J. (1996). The MAP kinaseaging, West Chester, PA). Fura-2 ratios were calibrated and con-
pathway controls differentiation from double-negative to double-verted to Ca2 concentrations using the equation of Grynkiewicz
positive thymocyte. Cell 86, 243–251.(Grynkiewicz et al., 1985).
da Silva, A.J., Li, Z., de Vera, C., Canto, E., Findell, P., and Rudd,
Measurement of T Cell Activation Markers C.E. (1997). Cloning of a novel T-cell protein FYB that binds FYN
Splenocytes were cultured at 1 	 106 /ml in either media alone or and SH2-domain- containing leukocyte protein 76 and modulates
media containing 3 g/ml soluble anti-CD3 (500A2; Pharmingen, interleukin 2 production. Proc. Natl. Acad. Sci. USA 94, 7493–7498.
La Jolla, CA) or 20 ng/ml PMA plus 0.2 g/ml ionomycin for 18–20 Ellis, J.H., Ashman, C., Burden, M.N., Kilpatrick, K.E., Morse, M.A.,
hr prior to analysis by flow cytometry as described above. Surface and Hamblin, P.A. (2000). GRID: a novel Grb-2-related adapter pro-
expression of activation markers was detected using biotinylated- tein that interacts with the activated T cell costimulatory receptor
anti-CD69 (APC-streptavidin) and FITC-anti-CD25. CD25 and CD69 CD28. J. Immunol. 164, 5805–5814.
surface expression were analyzed on gated Thy1.2-positive cells (all
Fang, N., and Koretzky, G.A. (1999). SLP-76 and Vav function inantibodies used in this assay are from Pharmingen, La Jolla, CA).
separate, but overlapping pathways to augment interleukin-2 pro-
moter activity. J. Biol. Chem. 274, 16206–16212.Acknowledgments
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